Diabetic Medication Update Gil C. Grimes, MD April 2007.
Revolution in Asian drug development: A Korea and Japan experience Henk de Koning Gans, MD VP, Process Management Global Development Japan Pharmacia KK,
Why we shouldn’t (yet) move to TDF/FTC as the primary first line regimen for PEPFAR-supported programs Barbara Marston, M.D. Care and Treatment Team, GAP,
